Search for: "MUTUAL PHARMACEUTICAL CO., INC." Results 61 - 80 of 173
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
1 Jul 2013, 5:34 am by Sean Wajert
The Supreme Court last week reversed the First Circuit decision in Mutual Pharmaceutical Co. v. [read post]
15 Mar 2013, 4:41 am by Rachel Sachs
For this blog, Ronald Mann previews Tuesday’s oral arguments in Mutual Pharmaceutical Co. v. [read post]
19 Sep 2013, 9:53 am by Bexis
Pfizer, Inc., 712 F.3d 21 (1st Cir. 2013), Aetna, Inc. v. [read post]
31 Oct 2013, 5:00 am
  We think that the opinion resembles the First Circuit’s decision in Mutual Pharmaceutical Co. v. [read post]
28 Dec 2007, 1:00 am
International Trade Commission and Flexsys America: CAFC instructs the ITC on claim construction: (IPBiz), (Patent Prospector), (more from IPBiz)Anonymised net drug sales might yet infringe - Eli Lilly & Company and Lilly Icos LLC v 8PM Chemists Ltd: (IPKat),Open source for cost effective drug discovery: (Spicy IP),Challenges to ethical and generic drug producers: (Profitability through simplicity),US: multiple courts - same patent: a… [read post]
26 Jul 2010, 12:52 pm by Robert Elliott, J.D.
According to the Department of Insurance the top five writers of workers comp insurance in Louisiana in 2009 were: LWCC with 24.4%, Liberty Mutual Group with 15.2%, LUBA Casualty Insurance Co. with 10%, American International Group with 8.8% and Zurich Group with 6.4%. [read post]
7 Jul 2008, 5:00 am
Ct. 1057 (2007), State Farm Mutual Automobile Insurance Co. v. [read post]
24 Aug 2011, 5:29 pm by Robert Elliott, J.D.
  Author Robert Elliott, executive vice president, Amaxx Risks Solutions, Inc. has worked successfully for 20 years with many industries to reduce Workers Compensation costs, including airlines, healthcare, printing/publishing, pharmaceuticals, retail, hospitality and manufacturing. [read post]
11 Mar 2013, 9:05 am by Stephen Wermiel
Implied preemption in a lawsuit over generic drugs is the focus of Mutual Pharmaceutical Co. v. [read post]
19 Mar 2014, 1:24 pm
Ever since Mutual Pharmaceutical Co. v. [read post]
9 Nov 2009, 5:00 am by Beck/Herrmann
Mutual Pharmaceutical Co., a New Hampshire federal court cited "the widespread rejection" of innovator liability as another reason to deny preemption, since such "rejection supports the view that, if failure-to-warn claims against generic drug makers are indeed pre-empted, those injured as a result … have no recourse. [read post]